Molecular detection and antimicrobial resistance pattern of carbapenem-resistant Klebsiella pneumoniae isolated from patients with lower respiratory tract infections
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262604Keywords:
Antimicrobial resistance, Carbapenem resistance, Klebsiella pneumoniae, Respiratory tract infectionsAbstract
Background: Recently worldwide, carbapenem-resistant Klebsiella pneumoniae (CRKP) infection has attracted a lot of attention because of the scarcity of effective drugs and the severity of the illness as well as the high death rate. This study was conducted to assess the antimicrobial susceptibility profiles and the molecular identification of CRKP isolates that were obtained from patients with lower respiratory tract infection (LRTI) at a tertiary care hospital in Sylhet, Bangladesh.
Methods: This cross-sectional study was conducted in the Department of Microbiology at Sylhet MAG Osmani Medical College, Sylhet, from July 2021 to June 2022. A total of 153 sputum samples were collected from adult patients (≥18 years) clinically diagnosed with LRTIs. Data were analyzed using SPSS version 26.
Result: Among 153 sputum samples from LRTI patients, 66.0% showed bacterial growth, with Klebsiella pneumoniae accounting for 20.9% of isolates. The mean age was 52.43±17.12 years with male predominance (69.3%). Of the Klebsiella pneumoniae isolates, 25.0% were carbapenem-resistant (CRKP), among which 75.0% produced carbapenemase and 50.0% harbored the KPC gene. Overall isolates showed high resistance to cephalosporins (up to 81.2%) and moderate sensitivity to carbapenems (around 72–75%) and amikacin (56.2%). CRKP isolates demonstrated marked multidrug resistance, with high resistance to most antibiotics, including carbapenems (75.0%).
Conclusion: In conclusion, one in every fourth KP isolate was CRKP, which highlighted the need for careful prescription of carbapenems for the therapy of infectious diseases with ESBL-producing KP. Among different genes conferring resistance to carbapenems, only the blaKPC gene was investigated in this study.
References
Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implications of antimicrobial resistance. J Korean Med Sci. 2006;21(5):816.
Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Genin R, Yvin JL. Severe community-acquired pneumonia: assessment of microbial aetiology as a mortality factor. European Resp J. 2004;24(5):779-85.
Aminul P, Anwar S, Molla MM, Miah MR. Evaluation of antibiotic resistance patterns in clinical isolates of Klebsiella pneumoniae in Bangladesh. Biosaf Health. 2021;3(06):301-6.
Tanni AA, Hasan MM, Sultana N, Ahmed W, Mannan A. Prevalence and molecular characterization of antibiotic resistance and associated genes in Klebsiella pneumoniae isolates: A clinical observational study in different hospitals in Chattogram, Bangladesh. PLoS One. 2021;16(9):257419.
Moradigaravand D, Martin V, Peacock SJ, Parkhill J. Evolution and epidemiology of multidrug-resistant Klebsiella pneumoniae in the United Kingdom and Ireland. MBio. 2017;8(1):10-128.
Levinson W, Chin-Hong P, Joyce EA, Nussbaum J, Schwartz BS. Review of medical microbiology & immunology: a guide to clinical infectious diseases. New York: McGraw-Hill Education. 2018.
Shanmugam P, Meenakshisundaram J, Jayaraman P. blaKPC gene detection in clinical isolates of carbapenem-resistant Enterobacteriaceae in a tertiary care hospital. J Clin Diagn Res. 2013;7(12):2736.
Emira AS, Madkour LA, Seif NE, Dwedar RA. Expressed and silent carbapenemase genes detected by multiplex PCR in both carbapenem-resistant and phenotypically-susceptible Gram-negative bacilli. Alexandria J Med. 2020;56(1):181-8.
Kamaladevi A, Gowrishankar S, Balamurugan K. Klebsiella spp. as Pathogens: Epidemiology, Pathogenesis, Identification, Treatment, and Prevention. Handbook of Foodborne Diseases. 2018:361-7.
Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front cell Infect Microbiol. 2018;8:4.
Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2014;3(3):743-58.
Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4(2):107-18.
Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW, Shu L, Yu J, Zhang R, Chen S. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37-46.
Van Belkum A, Dunne Jr WM. Next-generation antimicrobial susceptibility testing. J Clin Microbiol. 2013;51(7):2018-24.
McLaws M, WHO Guidelines Development Group. World Health Organization Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. World Health Organization. 2016.
Sharma SA, Bhat GK, Shenoy S. Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections. Indian J Med Microbiol. 2007;25(4):369-73.
Kumar AR. Antimicrobial sensitivity pattern of Klebsiella pneumoniae isolated from sputum from a tertiary care hospital, Surendranagar, Gujarat, and issues related to the rational selection of antimicrobials. Sch J App Med Sci. 2013;1(6):928-33.
Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures. Int] J Infect Dis. 2010;14(8):723-9.
Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682-707.
Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046-54.
Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791.
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
Panigrahi K, Pathi BK, Sahoo JP. Antimicrobial susceptibility profile of klebsiella pneumoniae isolates from a tertiary care hospital: a retrospective study. Cureus. 2025;17(10):87.
Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009–2012. Int J Antimicrob Agent. 2014;43(4):328-34.
Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin infectious Dis. 2011;53(1):60-7.
Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chem. 2014;58(2):654-63.
Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895.
Downloads
Published
How to Cite
Issue
Section
